LAS VEGAS– Thermo Fisher Scientific, the world leader in serving science, will demonstrate the benefits of collaborating to advance the science of transplantation and connecting breakthroughs to patients this week at the 48th Annual Meeting of the American Society for Histocompatibility & Immunogenetics (ASHI) Conference in Las Vegas. The innovations will be featured in a number of abstracts, three sponsored sessions and the launch of a new patient advocacy campaign, which can be seen at booth #100.
Among the innovations to be showcased by Thermo Fisher’s transplant diagnostics business are two separate multi-center studies at European, South American, Asian and United States transplant centers that were conducted to evaluate the One Lambda AllType FASTplex assay—a unique and easy-to-use next-generation sequencing assay for human leukocyte antigen (HLA) typing—in clinical settings. High-resolution genotyping of the HLA locus is key to ensuring the best donor–recipient match. The studies demonstrated robust performance and accurate typing results.
The leading maker of transplant diagnostics will also debut its Counting on you patient advocacy campaign, which celebrates the lives of transplant recipients by “counting” their extraordinary and everyday milestones post-transplant. The campaign also gives the recipients a platform to say thank you to their donors and the individuals whose work enables the lifesaving miracle of transplantation. The campaign represents the evolution of the company’s transplant patient advocacy efforts. Earlier this year, One Lambda, a Thermo Fisher Scientific brand, sponsored the Letters of Hope docuseries, which recently won an award for positive storylines related to organ transplantation.
“The work being done in transplant laboratories around the globe is the reason we are able to move the science of transplantation forward,” said Nicole Brockway, president, transplant diagnostics, Thermo Fisher Scientific. “We’re proud to partner with our customers to deliver the workflow of the future to help improve the quality of life for transplant recipients. As our new patient advocacy campaign vividly affirms, transplant recipients make the world a better place simply by being a part of it.”
Other One Lambda–branded technologies to be highlighted at the conference include TypeStream Visual NGS Analysis Software (TSV) and a unique, highly efficient, rapid, and accurate method for typing noncoding sequences that have been shown to be important to transplant patient outcomes.
